{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"Ta de Clinicagem","title":"TdC 83: Tratamento precoce para COVID-19","html":"<iframe width=\"100%\" height=\"180\" frameborder=\"no\" scrolling=\"no\" seamless src=\"https://share.transistor.fm/e/f30a7d89\"></iframe>","width":"100%","height":180,"duration":4064,"description":"Rapha, Joanne, Iago e Fred discutem os principais argumentos a favor do tratamento precoce e as evidências sobre as principais medicações. Para saber mais sobre nosso curso, entra lá no @tadeclinicagem ou cursotdc.com.br \r\n\r\nMinutagem \r\n(0:35) Curso TdC \r\n(3:55) Tratamento precoce COVID-19 \r\n(6:00) Fatores que fazem o paciente melhorar sem medicamentos \r\n(8:02) Experiências pessoais \r\n(10:15) Viés de confirmação\r\n(10:40) Reversão médica \r\n(15:30) Ônus da prova \r\n(18:30) Falácia ecológica \r\n(20:50) Mecanicismo \r\n(24:20) Hidroxicloroquina \r\n(30:36) Ivermectina \r\n(40:20) Corticoide \r\n(42:36) Azitromicina \r\n(44:00) Anticoagulação \r\n(47:08) Vitaminas \r\n(55:23) Nova droga \r\n(58:28) Covid na Prática \r\n(1:00:30) Mensagem final \r\n(1:02:50) Salves \r\n(1:05:40) Desafio da semana anterior \r\n(1:06:34) Desafio da semana \r\n\r\nReferências: \r\n1- HARTMAN, Steve E. Why do ineffective treatments seem helpful? A brief review. Chiropractic & osteopathy, v. 17, n. 1, p. 1-7, 2009. \r\n2- ROCCO, Patricia RM et al. Early use of nitazoxanide in mild Covid-19 disease: randomised, placebo-controlled trial. European Respiratory Journal, 2020. \r\n3- https://twitter.com/azavascki/status/1319732851273797632 \r\n4- HASTIE, Claire E. et al. Vitamin D concentrations and COVID-19 infection in UK Biobank. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, v. 14, n. 4, p. 561-565, 2020. \r\n5- MELTZER, David O. et al. Association of vitamin D status and other clinical characteristics with COVID-19 test results. JAMA network open, v. 3, n. 9, p. e2019722-e2019722, 2020. \r\n6- MURAI, Igor H. et al. Effect of a single high dose of vitamin D3 on hospital length of stay in patients with moderate to severe COVID-19: a randomized clinical trial. Jama, v. 325, n. 11, p. 1053-1060, 2021. \r\n7- VIMALESWARAN, Karani S.; FOROUHI, Nita G.; KHUNTI, Kamlesh. Vitamin D and covid-19. 2021. \r\n8- https://clinicaltrials.gov/ct2/show/NCT04344041 \r\n9- https://clinicaltrials.gov/ct2/show/NCT04579640 \r\n10- COVID-19 rapid...","thumbnail_url":"https://img.transistorcdn.com/lqcQlEC1m6aWV5CJqKTqNKKWbLXziZKK97FisF4ZuuE/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9lODM1/ZmI0ODIxZjAxM2U1/ZGUwMjhkYTYwNzZi/MGNmNi5qcGc.webp","thumbnail_width":300,"thumbnail_height":300}